Who is sponsoring NCT04821128?

NCT04821128 is sponsored by Hospices Civils de Lyon.

What drugs are being tested in NCT04821128?

Interventions in NCT04821128: Radiologic and pathological review..

What condition does NCT04821128 study?

NCT04821128 studies Oral Squamous, Cell Carcinoma.

Is NCT04821128 still recruiting?

NCT04821128 is currently status unknown. Last updated 29 March 2021.

Last reviewed 2021-03-29 · How we verify

NCT04821128: RaP E ToC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Radio/Pathological Evaluation of Tongue Cancer Infiltration

Status unknown Last updated 29 March 2021

What this trial tests

trial testing Radiologic and pathological review. in Oral Squamous in 200 participants. Status unknown.

Timeline

27 November 2020

Primary endpoint
27 November 2020

27 May 2021

Quick facts

Lead sponsor	Hospices Civils de Lyon
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	27 November 2020
Primary completion	27 November 2020
Estimated completion	27 May 2021
Sites	1 location across France

Drugs / interventions tested

Radiologic and pathological review.

Conditions studied

Oral Squamous — all drugs for Oral Squamous →
Cell Carcinoma — all drugs for Cell Carcinoma →

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

Eligibility, any sex, with Oral Squamous or Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the good correlation and prediction of the DOI for the post-operative pathological results and prognosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04821128 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
Last refreshed: 29 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04821128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing